Zhang et al., 2017 - Google Patents
Phosphorylated calmodulin promotes PI3K activation by binding to the SH2 domainsZhang et al., 2017
View HTML- Document ID
- 7361725782706153802
- Author
- Zhang M
- Jang H
- Gaponenko V
- Nussinov R
- Publication year
- Publication venue
- Biophysical Journal
External Links
Snippet
How calmodulin (CaM) acts in KRAS-driven cancers is a vastly important question. CaM binds to and stimulates PI3Kα/Akt signaling, promoting cell growth and proliferation. Phosphorylation of CaM at Tyr 99 (pY99) enhances PI3Kα activation. PI3Kα is a lipid kinase …
- 108010041952 Calmodulin 0 title abstract description 138
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
- G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Phosphorylated calmodulin promotes PI3K activation by binding to the SH2 domains | |
Hasan et al. | Ca2+ regulation of TRP ion channels | |
Chin et al. | Calmodulin: a prototypical calcium sensor | |
Lu et al. | Ras conformational ensembles, allostery, and signaling | |
Bunney et al. | PLC regulation: emerging pictures for molecular mechanisms | |
Lockyer et al. | CAPRI regulates Ca2+-dependent inactivation of the Ras-MAPK pathway | |
Lebensohn et al. | Activation of the WAVE complex by coincident signals controls actin assembly | |
Liu et al. | Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors | |
Salas-Estrada et al. | Lipids alter rhodopsin function via ligand-like and solvent-like interactions | |
Uhart et al. | Human 14-3-3 paralogs differences uncovered by cross-talk of phosphorylation and lysine acetylation | |
Milanesi et al. | The regulatory role of key metabolites in the control of cell signaling | |
Muftuoglu et al. | Mechanism of substrate specificity of phosphatidylinositol phosphate kinases | |
Di Marino et al. | MD and docking studies reveal that the functional switch of CYFIP1 is mediated by a butterfly-like motion | |
Li et al. | Interactions of protein kinase C-α C1A and C1B domains with membranes: a combined computational and experimental study | |
Yu et al. | Molecular determinants conferring the stoichiometric-dependent activity of α-conotoxins at the human α9α10 nicotinic acetylcholine receptor subtype | |
Zhang et al. | Calmodulin (CaM) activates PI3Kα by targeting the “soft” CaM-binding motifs in both the nSH2 and cSH2 domains of p85α | |
Llorach-Pares et al. | Meridianins and lignarenone B as potential GSK3β inhibitors and inductors of structural neuronal plasticity | |
Zheng et al. | Structural insights into Ras regulation by SIN1 | |
Huang et al. | Electrostatic recognition and induced fit in the κ-PVIIA toxin binding to Shaker potassium channel | |
Grycova et al. | Ca2+ Binding protein S100A1 competes with calmodulin and PIP2 for binding site on the C-terminus of the TPRV1 receptor | |
Wang et al. | Interaction of calmodulin with the cSH2 domain of the p85 regulatory subunit | |
Ahmed et al. | F-BAR domain proteins: Families and function | |
Yekefallah et al. | Cooperative gating of a K+ channel by unmodified biological anionic lipids viewed by solid-state NMR spectroscopy | |
Righino et al. | Structural model of the full-length Ser/Thr protein kinase StkP from S. pneumoniae and its recognition of peptidoglycan fragments | |
Della Longa et al. | A dynamic picture of the early events in nociceptin binding to the NOP receptor by metadynamics |